Vanqua Bio
Signal active
Organization
Contact Information
Overview
Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases. The company's technology platform utilizes human genetics and patient-derived neuronal cells to identify, validate, and clinically translate novel disease pathways associated with lysosomal dysfunction or aberrant activation of the innate immune system.
About
Industries
Biotechnology, Health Care, Medical
Founded
2019
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Vanqua Bio headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical sector. The company focuses on Biotechnology and has secured $4.7B in funding across 36 round(s). With a team of 11-50 employees, Vanqua Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Vanqua Bio, raised $45.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
0
Lead Investors
0
Total Funding Amount
$130.0M
Details
1
Vanqua Bio has raised a total of $130.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Early Stage Venture | 85.0M |
Investors
Vanqua Bio is funded by 12 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Vanqua Bio | - | FUNDING ROUND - Vanqua Bio | 85.0M |
| Logos Capital | - | FUNDING ROUND - Logos Capital | 85.0M |
| Vanqua Bio | - | FUNDING ROUND - Vanqua Bio | undefined |
| The Silverstein Foundation | - | FUNDING ROUND - The Silverstein Foundation | undefined |
Recent Activity
There is no recent news or activity for this profile.